Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
- 28 March 2013
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 44 (2) , 426-433
Abstract
Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer <1 cm, in the absence of other higher risk features. We retrospectively studied low-risk patients (pts) with differentiated thyroid cancer (DTC) less than 1 cm recruited for radioiodine therapy (RAI). Methods: 91 pts (79 women, age 48.4 ± 12 yrs) with DTC were enrolled for RAI. Patients underwent pre-therapy ultrasonography (US), those with suspected/ambiguous lymph-nodes were excluded and proposed for cytology. Treated pts underwent post-therapeutic whole body scan (WBSt) completed by neck/chest SPECT/CT, when necessary (e.g. evidence of uptake outside of thyroid bed). A target lesion on SPECT/CT was defined as an identifiable lymph-nodal site presenting a matched significant iodine uptake. The patients were followed up for 14 ± 2 months thereafter. Results: All pts/cancers were pT1. The mean histological diameter was 0.68 ± 0.23 cm. Six patients were excluded because of suspected nodal involvement at US. Thirty (35 %) out of 85 pts had suspicious WBSt as per lymph-nodal involvement which was confirmed at the subsequent SPECT/CT acquisition in most part of pts (26/30; 86 %). Overall detected target lesions was 34, and nine (26 %) had interim positive fine needle cytology. Conclusions: a significant part of low risk DTC patients, for whom RAI is not recommended, presents an incidental suspicion of lymph-nodal involvement at WBSt confirmed by subsequent SPECT/CT. Such setting would have not been treated by I-131.Keywords
This publication has 38 references indexed in Scilit:
- Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablationClinical Endocrinology, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2009
- ATA Guidelines: Do Patients with Stage I Thyroid Cancer Benefit From 131 I?Thyroid®, 2007
- Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patientsEuropean Journal of Surgical Oncology, 2006
- Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer StagingAnnals of Surgical Oncology, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- The prognostic value of primary tumor size in papillary and follicular thyroid carcinomaCancer, 2005
- Symptomatic versus Asymptomatic Papillary Thyroid Microcarcinoma: A Retrospective Analysis of Surgical Outcome and Prognostic Factors.Endocrine Journal, 1999
- The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patientsThe Journal of Clinical Endocrinology & Metabolism, 1992